CDK4/6 inhibitor-SHR6390 exerts potent antitumor activity in esophageal squamous cell carcinoma by inhibiting phosphorylated Rb and inducing G1 cell cycle arrest

被引：0

作者：

Jiayuan Wang

Qingqing Li

Jiajia Yuan

Jingyuan Wang

Zuhua Chen

Zhentao Liu

Zhongwu Li

Yumei Lai

Jing Gao

Lin Shen

机构：

[1] Peking University Cancer Hospital and Institute,Department of Gastrointestinal Oncology, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing)

[2] Peking University Cancer Hospital and Institute,Department of Pathology, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing)

来源：

Journal of Translational Medicine | / 15卷

关键词：

CDK4/6 inhibitor; ESCC; Cell cycle arrest; pRb;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

共 50 条

[21] Molecular interplay between cdk4 and p21 dictates G0/G1 cell cycle arrest in prostate cancer cells
Gulappa, Thippeswamy
Reddy, Ramadevi Subramani
Suman, Suman
Nyakeriga, Alice M.
Damodaran, Chendil
CANCER LETTERS, 2013, 337 (02) : 177 - 183
[22] Transcription factor NFYA promotes G1/S cell cycle transition and cell proliferation by transactivating cyclin D1 and CDK4 in clear cell renal cell carcinoma
Li, Yu
Xiao, Xing
Chen, Hengxing
Chen, Zhen
Hu, Kaishun
Yin, Dong
AMERICAN JOURNAL OF CANCER RESEARCH, 2020, 10 (08): : 2446 - 2463
[23] Cyclin-Dependent Kinase Inhibitor 3 Promoted Cell Proliferation by Driving Cell Cycle from G1 to S Phase in Esophageal Squamous Cell Carcinoma
Liu, Juan
Min, Li
Zhu, Shengtao
Guo, Qingdong
Li, Hengcun
Zhang, Zheng
Zhao, Yu
Xu, Changqin
Zhang, Shutian
JOURNAL OF CANCER, 2019, 10 (08): : 1915 - 1922
[24] Prolonged early G1 arrest by selective CDK4/CDK6 inhibition sensitizes myeloma cells to cytotoxic killing through cell cycle-coupled loss of IRF4
Huang, Xiangao
Di Liberto, Maurizio
Jayabalan, David
Liang, Jun
Ely, Scott
Bretz, Jamieson
Shaffer, Arthur L., III
Louie, Tracey
Chen, Isan
Randolph, Sophia
Hahn, William C.
Staudt, Louis M.
Niesvizky, Ruben
Moore, Malcolm A. S.
Chen-Kiang, Selina
BLOOD, 2012, 120 (05) : 1095 - 1106
[25] p53-dependent repression of cdk4 synthesis in transforming growth factor-beta-induced G1 cell cycle arrest
Ewen, ME
JOURNAL OF LABORATORY AND CLINICAL MEDICINE, 1996, 128 (04): : 355 - 360
[26] Targeting G1/S phase cell-cycle genomic alterations and accompanying co-alterations with individualized CDK4/6 inhibitor-based regimens
Kato, Shumei
Okamura, Ryosuke
Adashek, Jacob J.
Khalid, Noor
Lee, Suzanna
Van Nguyen
Sicklick, Jason K.
Kurzrock, Razelle
JCI INSIGHT, 2021, 6 (01)
[27] Coleusin factor exerts cytotoxic activity by inducing G0/G1 cell cycle arrest and apoptosis in human gastric cancer BGC-823 cells
Sun, Bo
Geng, Shuo
Huang, Xiaojia
Zhu, Jin
Liu, Shu
Zhang, Yajing
Ye, Jian
Li, Yongjin
Wang, Jingze
CANCER LETTERS, 2011, 301 (01) : 95 - 105
[28] Licochalcone C induces cell cycle G1 arrest and apoptosis in human esophageal squamous carcinoma cells by activation of the ROS/MAPK signaling pathway
Kwak, Ah-Won
Choi, Joon-Seok
Liu, Kangdong
Lee, Mee-Hyun
Jeon, Young-Joo
Cho, Seung-Sik
Yoon, Goo
Oh, Ha-Na
Chae
Shim, Jung-Hyun
JOURNAL OF CHEMOTHERAPY, 2020, 32 (03) : 132 - 143
[29] Selective CDK4/6 inhibition of novel 1,2,3-triazole tethered acridinedione derivatives induces G1/S cell cycle transition arrest via Rb phosphorylation blockade in breast cancer models
Praveenkumar, E.
Gurrapu, Nirmala
Kolluri, Prashanth Kumar
Shivaraj
Subhashini, N. J. P.
Dokala, Appaji
BIOORGANIC CHEMISTRY, 2021, 116
[30] The CDK 4/CDK 6 Inhibitor PD0332991 significantly reduces cell growth via a G1 phase arrest in Mantle Cell Lymphoma cell lines and additively increases effects of Ibrutinib
Zoellner, A-K
Dietzfelbinger, R.
Hutter, G.
Zimmermann, Y.
Hiddemann, W.
Dreyling, M.
ONKOLOGIE, 2013, 36 : 198 - 198

← 1 2 3 4 5 →